1. Home
  2. NRDY vs NKTX Comparison

NRDY vs NKTX Comparison

Compare NRDY & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nerdy Inc.

NRDY

Nerdy Inc.

N/A

Current Price

$1.13

Market Cap

155.4M

Sector

Technology

ML Signal

N/A

Logo Nkarta Inc.

NKTX

Nkarta Inc.

N/A

Current Price

$1.77

Market Cap

129.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NRDY
NKTX
Founded
2007
2015
Country
United States
United States
Employees
N/A
157
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
155.4M
129.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NRDY
NKTX
Price
$1.13
$1.77
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$1.25
$13.25
AVG Volume (30 Days)
1.5M
623.5K
Earning Date
11-06-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$177,867,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$1.31
52 Week High
$2.18
$2.74

Technical Indicators

Market Signals
Indicator
NRDY
NKTX
Relative Strength Index (RSI) 45.39 40.56
Support Level $1.34 $1.81
Resistance Level $1.49 $1.90
Average True Range (ATR) 0.12 0.07
MACD -0.01 0.01
Stochastic Oscillator 1.37 20.00

Price Performance

Historical Comparison
NRDY
NKTX

About NRDY Nerdy Inc.

Nerdy Inc is a curated direct-to-consumer platform for live online learning. Its proprietary platform leverages technology, including artificial intelligence ("AI"), to connect students, users, parents, guardians, and purchasers of all ages to tutors, instructors, subject matter experts, educators, and other professionals. The company provides learning experiences across numerous subjects and multiple formats, including one-on-one instruction, small group tutoring, large format classes, tutor chat, essay review, adaptive assessments, and self-study tools. The company generates revenue by selling services to learners and institutions for one-on-one instruction and small group tutoring.

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Share on Social Networks: